Cantitate/Preț
Produs
Total produse
Vezi coșul
Combination Cancer Therapy: Modulators and Potentiators de Gary K. Schwartz

Combination Cancer Therapy: Modulators and Potentiators: Cancer Drug Discovery and Development

Editat de Gary K. Schwartz
en Limba Engleză Paperback – 25 noi 2014
Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future treatments in cancer therapy.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 76305 lei  6-8 săpt.
  Humana Press Inc. – 25 noi 2014 76305 lei  6-8 săpt.
Hardback (1) 108032 lei  6-8 săpt.
  Humana Press Inc. – 3 dec 2004 108032 lei  6-8 săpt.

Din seria Cancer Drug Discovery and Development

  • 5% CNS Cancer: Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches
    Preț: 144506 lei
  • 5% Developments in T Cell Based Cancer Immunotherapies
    Preț: 108589 lei
  • 5% mTOR Pathway and mTOR Inhibitors in Cancer Therapy
    Preț: 138701 lei
  • 5% Antiangiogenic Agents in Cancer Therapy
    Preț: 137019 lei
  • 5% Tumor Models in Cancer Research
    Preț: 142282 lei
  • 5% Telomeres and Telomerase in Cancer
    Preț: 131674 lei
  • 5% Gene Therapy for Cancer
    Preț: 141031 lei
  • 5% Proteasome Inhibitors in Cancer Therapy
    Preț: 109106 lei
  • 5% Oncogene-Directed Therapies
    Preț: 110341 lei
  • 24% Protein Tyrosine Kinases: From Inhibitors to Useful Drugs
    Preț: 103759 lei
  • 5% Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention
    Preț: 143661 lei
  • 5% Apoptosis, Senescence and Cancer
    Preț: 135078 lei
  • 5% Bioinformatics in Cancer and Cancer Therapy
    Preț: 138878 lei
  • 5% Bone Metastasis
    Preț: 109091 lei
  • 5% Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy
    Preț: 139957 lei
  • 5% Tumor Suppressor Genes in Human Cancer
    Preț: 140079 lei
  • 5% Platinum-Based Drugs in Cancer Therapy
    Preț: 76628 lei
  • 5% Regional Cancer Therapy
    Preț: 140939 lei
  • 5% Checkpoint Controls and Targets in Cancer Therapy
    Preț: 108781 lei
  • 5% Antifolate Drugs in Cancer Therapy
    Preț: 140529 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy
    Preț: 136582 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology
    Preț: 143143 lei
  • 5% Farnesyltransferase Inhibitors in Cancer Therapy
    Preț: 108442 lei
  • 5% Supportive Care in Cancer Therapy
    Preț: 98218 lei
  • 5% Nucleic Acid Therapeutics in Cancer
    Preț: 71309 lei
  • 5% Stem Cells and Cancer
    Preț: 133176 lei
  • 5% EGFR Signaling Networks in Cancer Therapy
    Preț: 129740 lei
  • 5% Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics
    Preț: 110180 lei
  • 5% Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
    Preț: 140403 lei
  • 5% Hormone Therapy in Breast and Prostate Cancer
    Preț: 108838 lei
  • 5% Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications
    Preț: 131776 lei
  • 5% The Oncogenomics Handbook
    Preț: 143518 lei
  • 5% Macromolecular Anticancer Therapeutics
    Preț: 190025 lei
  • 5% Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions
    Preț: 138969 lei
  • 5% Cancer Drug Resistance
    Preț: 140976 lei
  • 5% Matrix Metalloproteinase Inhibitors in Cancer Therapy
    Preț: 107799 lei
  • 5% Fluoropyrimidines in Cancer Therapy
    Preț: 108746 lei
  • 5% In Vivo Imaging of Cancer Therapy
    Preț: 99058 lei
  • 5% The Tumor Microenvironment
    Preț: 141387 lei
  • 5% Camptothecins in Cancer Therapy
    Preț: 139992 lei
  • 5% Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins
    Preț: 77165 lei
  • 5% Cancer Proteomics: From Bench to Bedside
    Preț: 131172 lei
  • 5% Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
    Preț: 133176 lei
  • 5% COX-2 Blockade in Cancer Prevention and Therapy
    Preț: 109054 lei
  • 5% Cytokines in the Genesis and Treatment of Cancer
    Preț: 141154 lei

Preț: 76305 lei

Preț vechi: 80321 lei
-5% Nou

Puncte Express: 1145
Preț estimativ în valută:
14608€ • 15184$ • 12112£

Carte tipărită la comandă

Livrare economică 06-20 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781627038065
ISBN-10: 162703806X
Pagini: 296
Ilustrații: X, 284 p.
Dimensiuni: 155 x 235 x 16 mm
Greutate: 0.42 kg
Ediția:2005
Editura: Humana Press Inc.
Colecția Humana
Seria Cancer Drug Discovery and Development

Locul publicării:Totowa, NJ, United States

Public țintă

Research

Cuprins

Targeting of the EGFR As a Modulator of Cancer Chemotherapy.- Cyclin-Dependent Kinase Inhibitors in Combination Chemotherapy.- Development of Protein Kinase C and Cyclin-Dependent Kinase Inhibitors As Potentiators of Cytotoxic Drug Action in Leukemia.- Carboxyamidotriazole, an Inhibitor of Nonvoltage-Operated Calcium Entry.- Targeted ?-Particle Therapy.- Pharmacological Modulation of Fluoropyrimidines.- Development of Inhibitors of HER2 With Taxanes.- Targeting NF-?B to Increase the Activity of Cisplatin in Solid Tumors.- Combinations of Chemotherapy and G3139, an Antisense Bcl-2 Oligonucleotide.- Use of Animal Models to Evaluate Signal Transduction Inhibitors As Modulators of Cytotoxic Therapy.

Recenzii

"It offers everyone in the field of cancer drug development and therapy a powerful new understanding of the optimal sequencing and scheduling of new combination drug therapies necessary to maximize the effects of cancer patients." - Neoplasma

Textul de pe ultima copertă

Early clinical trials of the new molecular-based anticancer agents have shown that many are marginal in controlling cancer, but prove to be potent modulators and potentiators of chemotherapy-induced apoptosis when used in combination with classic cytotoxic drugs or radiation. In Combination Cancer Therapy: Modulators and Potentiators, expert physician-scientists and clinicians with first-hand experience in the clinical development of targeted therapies review those combinations that hold the most promise for the future of medical oncology, detailing their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory benchtop to the patient's bedside as a new generation of cancer therapeutics.
Cutting-edge and forward-looking, Combination Cancer Therapy: Modulators and Potentiators offers everyone in the fields of cancer drug development and therapy a powerful new understanding of the optimal sequencing and scheduling of new combination drug therapies necessary to maximize the effects for cancer patients today.

Caracteristici

Includes supplementary material: sn.pub/extras